CHICAGO, Sept. 30, 2026 — Advocate Health Care marked a new chapter in cancer care today, breaking ground on a new Comprehensive Cancer Center on the campus of Advocate Lutheran General Hospital in Park Ridge. The $99 million investment will expand access to specialized cancer services and treatments, bringing advanced cancer care closer to home for patients and families.
“As a surgeon, I see how cancer care improves when the right medical minds come together around one patient, one plan and the latest advances in treatment and research. This investment will make that individualized, team-based care more accessible to patients across our community,” said Dr. Nikolaos Dallas, vice president of Advocate Health’s national cancer service line, Illinois Division. “It’s about earlier diagnoses, better outcomes and fewer north suburban families losing a loved one to cancer.”
The two-story, 77,000-square-foot facility will bring medical and surgical oncology, hematology, Transplant and Cellular Therapy, infusion and survivorship services together in one location. Designed to meet the growing need for cancer care and reduce the time patients spend navigating between services, the center will feature 73 infusion treatment bays, a dedicated oncology pharmacy and laboratory services to support diagnosis and treatment.
“When someone hears the words ‘you have cancer,’ they need more than treatment. They need to know they have a team beside them and access to specialized care close to home,” said Allison Wyler, president of the North Chicago Area for Advocate Health Care and president of Advocate Lutheran General Hospital. “This new Comprehensive Cancer Center will assemble the specialists, treatments and support patients and families need throughout their cancer journey.”
Patients will also have access to Advocate Health’s clinical research network, with more than 200 ongoing studies offering opportunities to take part in clinical trials and innovative approaches to cancer care.
Advocate Lutheran General offers one of the region’s leading Transplant and Cellular Therapy programs, including CAR T-cell therapy, an advanced treatment that uses a patient’s own immune cells to recognize and attack cancer cells. The program also provides apheresis, which collects the blood components needed for certain cellular therapies.
The Comprehensive Cancer Center is expected to open in spring 2028.